The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033.
The Synthetic Biology by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Synthetic Biology Market:
https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report
According to The Business Research Company’s Synthetic Biology, The synthetic biology market size has grown exponentially in recent years. It will grow from $16.59 billion in 2023 to $21.02 billion in 2024 at a compound annual growth rate (CAGR) of 26.7%. The growth in the historic period can be attributed to increasing healthcare and life science facilities, increasing investment in drug, wide application in end-user industries, low cost of dna sequencing and synthesizing, and rise in funding. The synthetic biology market size is expected to see exponential growth in the next few years. It will grow to $45.83 billion in 2028 at a compound annual growth rate (CAGR) of 21.5%.
The increasing demand for personalized medicine is expected to drive the growth of the synthetic biology market. Personalized medicine, also known as precision medicine, involves tailoring medical treatments and therapies to the specific characteristics of individual patients. Synthetic biology plays a crucial role in personalized medicine by providing powerful tools and techniques to customize medical interventions based on an individual’s unique genetic and molecular profile. For example, in 2023, the Personalized Medicine Coalition reported that the FDA approved personalized medicines for 34% of new drugs, marking a significant increase compared to previous years. This trend indicates the growing importance of personalized medicine in drug development and healthcare, consequently fueling the expansion of the synthetic biology market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=2508&type=smp
The synthetic biology market covered in this report is segmented –
1) By Technology: Nucleotide Synthesis And Sequencing, Bioinformatics, Microfluidics, Genetic Engineering
2) By Product Type: Oligonucleotides, Enzymes, Cloning And Assembly Kits, Xeno-Nucleic Acids (XNA), Chassis Organism
3) By Application: Pharmaceuticals And Diagnostics, Chemicals, Biofuels, Bioplastics, Other Application
Top Major Players
Thermo Fisher Scientific Inc.,
Danaher Corporation,
Eurofins Scientific,
Merck KGaA,
Novozymes A/S
The synthetic biology market report table of contents includes:
1. Executive Summary
- Synthetic Biology Market Characteristics
- Synthetic Biology Market Trends And Strategies
- Synthetic Biology Market – Macro Economic Scenario
- Global Synthetic Biology Market Size and Growth
- Synthetic Biology Market Segmentation
- Synthetic Biology Market Regional And Country Analysis
…………….
- Key Mergers And Acquisitions In The Synthetic Biology Market
- Synthetic Biology Market Future Outlook and Potential Analysis
- Appendix
List Of Tables :
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Synthetic Biology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Synthetic Biology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Synthetic Biology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
………………
Table 74: Thermo Fisher Scientific Inc Financial Performance
Table 75: Danaher Corporation Financial Performance
Table 76: Eurofins Scientific Financial Performance
Table 77: Merck KGaA Financial Performance
Table 78: Novozymes A/S Financial Performance
Read Related Reports :
https://topprnews.com/lending-market-share/
https://goodprnews.com/life-and-health-reinsurance-market-trends/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
